Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=22694840
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS/SVU corrected 2012
appropriate use criteria for peripheral vascular ultrasound and physiological
testing part I: arterial ultrasound and physiological testing: a report of the
American College of Cardiology Foundation appropriate use criteria task force,
American College of Radiology, American Institute of Ultrasound in Medicine,
American Society of Echocardiography, American Society of Nephrology,
Intersocietal Commission for the Accreditation of Vascular Laboratories, Society
for Cardiovascular Angiography and Interventions, Society of Cardiovascular
Computed Tomography, Society for Interventional Radiology, Society for Vascular
Medicine, Society for Vascular Surgery, corrected and Society for Vascular
Ultrasound corrected
#MMPMID22694840
Mohler ER 3rd
; Gornik HL
; Gerhard-Herman M
; Misra S
; Olin JW
; Zierler RE
; Wolk MJ
; Mohler ER 3rd
J Am Coll Cardiol
2012[Jul]; 60
(3
): 242-76
PMID22694840
show ga
The American College of Cardiology Foundation (ACCF), in partnership with key
specialty and subspecialty societies, conducted a review of common clinical
scenarios where noninvasive vascular testing (ultrasound and physiological
testing) is frequently considered. The indications (clinical scenarios) were
derived from common applications or anticipated uses, as well as from current
clinical practice guidelines and results of studies examining the implementation
of the original appropriate use criteria (AUC). The 159 indications in this
document were developed by a diverse writing group and scored by a separate
independent technical panel on a scale of 1 to 9, to designate appropriate use
(median 7 to 9), uncertain use (median 4 to 6), and inappropriate use (median 1
to 3). A total of 255 indications (with the inclusion of surveillance timeframes)
were rated. One hundred and seventeen indications were rated as appropriate, 84
were rated as uncertain, and 54 were rated as inappropriate. The AUC for
peripheral vascular disease have the potential to impact physician decision
making, healthcare delivery, and reimbursement policy. Furthermore, recognition
of uncertain clinical scenarios facilitates identification of areas that would
benefit from future research.